glp 1 drugs tirzepatide FDA says shortage of GLP-1 drug is over Weighing benefits, risks of GLP-1

Collectively, these segments are projected to contribute over $129 billion in market value by 2030, driven by rising prevalence of diabetes and obesity, increasing adoption of incretin-based therapies, and expanding clinical use in weight management and metabolic disorders

Company terms were last updated January 1, 2024 according to the website

Patients who maintain consistent protein intake (0.8 to 1.2 grams per kilogram of body weight daily) preserve lean muscle mass and metabolic rate during weight loss, preventing the downward metabolic spiral that amplifies plateaus

Sulforaphane increases glutathione in the brain | Jed Fahey Enter your email to get our 15-page guide to sprouting broccoli and learn about the science of chemoprotective compount sulforaphane

The widespread promotion of the drug, including on TV ads, streetcar wraps, sports games and social media, reinforces the idea that weight loss should always be the end goal